Humana Inc.

NYSE:HUM

Medical - Healthcare Plans

Healthcare
$385.71 +0.19%

+$0.70 today

Market cap
$46.32B
Beta
0.77
P/E (TTM)
38.6
EPS (TTM)
$9.39
Dividend yield
0.98%
52W Low $163.11High $380.86

Volume 4.06M

Average 1.72M

HUM Operating Income

Profit from core operations after operating expenses, before interest and taxes.

Humana Inc.NYSE: HUM

Operating Income · Q3 FY2026 · quarter ended Sep 2026

Operating income dips below year-ago levels

Q3 FY2026 operating income of $75M fell 30.6% year over year, behind the +26.0% change in trailing-twelve-month operating income. Sequentially, it fell 94.5% from the prior quarter. Over 3 fiscal years it compounded at -25.9% a year.

Context

  • Operating income amounted to 1.1% of revenue in FY2025, down 0.3 pp from a year earlier.
  • Operating income increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether operating income reaches the consensus estimate from 14 analysts of $2.04B (+40.6%) for the fiscal year ending Dec 2026, a step up from the -10.7% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$75M-94.5% QoQ
Last fiscal yearDec 2025
$1.45B-10.7% YoY
LTMSep 2026
$1.99B+26.0% YoY
Operating Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-30.6%+29.5%+60.0 pp
1 year-10.7%+40.6%+51.3 pp
3-year CAGR-25.9%+57.5%+83.4 pp
5-year CAGR+32.3%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Income history

USD · from the income statement

Latest · FY2025
1.45B USD
Year-over-year change
-10.7%
4-year CAGR
-19.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Income vs competitors

How HUM compares with its peers on the latest reported figures

  • HUM's LTM Sep 2026 operating income of $1.99B is the 5th highest of the 9 companies compared; the peer median is $4.04B.
  • Its year-over-year change of +26.0% is the 3rd highest of 9, against a peer median of -8.3%.
  • Operating income amounts to 1.3% of revenue for HUM, versus a peer median of 3.1%.
HUM Competitors Peer median
Operating Income for HUM and competitors
Company Period LTM YoY 3-year CAGR% of revenue
UNHUnitedHealth Group IncorporatedLTM Sep 2026$23.92B -9.2%-12.6%5.3%
CICigna CorporationLTM Sep 2026$9.58B +4.6%+2.6%3.3%
CVSCVS Health CorporationLTM Jun 2026$8.29B -7.4%+9.3%2.0%
ELVElevance Health Inc.LTM Sep 2026$7.46B -12.0%-1.4%3.7%
HUMHumana Inc.LTM Sep 2026$1.99B +26.0%-25.9%1.3%
OSCROscar Health, Inc.LTM Jun 2026$624.1M +567.8%—4.1%
MOHMolina Healthcare, Inc.LTM Sep 2026$172M -87.0%-17.3%0.4%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$35.65M +154.1%—0.8%
CNCCentene CorporationLTM Jun 2026-$5.46B -384.9%—2.8%
Peer median (excluding HUM) $4.04B-8.3%-1.4%3.1%

Competitors are the stored peer set for HUM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue83.65B92.92B106.44B117.81B129.66B
Cost of Revenue69.2B75.69B88.39B100.66B110.81B
Gross Profit14.45B17.23B18.05B17.15B18.85B
Gross Margin17.3%18.5%17.0%14.6%14.5%
Research & Development00000
Selling, General & Admin00000
Operating Expenses11.03B13.67B14.73B15.52B17.4B
Depreciation & Amortization713M845M917M968M824M
EBITDA4.46B4.81B4.73B3.26B2.91B
EBITDA Margin5.3%5.2%4.4%2.8%2.2%
Operating Income3.42B3.56B3.32B1.63B1.45B
Operating Margin4.1%3.8%3.1%1.4%1.1%
Interest Income00000
Interest Expense326M401M493M660M631M
Other Income / Expenses00000
Income Before Tax3.42B3.56B3.32B1.63B1.45B
Pre-Tax Margin4.1%3.8%3.1%1.4%1.1%
Income Tax Expense485M762M836M413M250M
Net Income2.93B2.81B2.49B1.21B1.19B
Net Margin3.5%3.0%2.3%1.0%0.9%
EPS (Basic)22.7922.2020.0910.019.87
EPS (Diluted)22.6722.0820.009.989.84
Weighted Avg Shares128.69M126.42M123.87M120.57M120.45M
Weighted Avg Shares (Diluted)129.4M127.09M124.44M120.87M120.83M

Humana Inc.

NYSE:HUM

Intrinsic Alpha fair value

Locked

Current Price

$385.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.